Literature DB >> 1107120

Tolbutamide-induced changes of the DNA, protein and insulin content and the secretory activity of isolated rat pancreatic islets.

P Schauder, H Frerichs.   

Abstract

Following prolonged administration of tolbutamide the DNA- and protein content per islet was enhanced but the IRI content per islet was diminished. Glucose-induced (2.0, 8.0 or 16.6 mM) and leucine-induced (12.5 or 25.0 mM) IRI release from isolated islets, as well as 14C02-production from U-14C glucose, were decreased. Theophylline (5.0 mM) restored the glucose sensitivity of the islets towards normal. The results indicate that tolbutamide-induced islet cell hyperplasia does not entail islet hyperfunction, as previously thought. Decreased IRI release may partially be explained by a tolbutamide-induced alteration of the adenylate cyclase/phosphodiesterase system of the B-cell.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1107120     DOI: 10.1007/bf00422395

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  41 in total

1.  B CELL HYPERFUNCTION AFTER LONG-TERM SULFONYLUREA TREATMENT.

Authors:  B W VOLK; S S LAZARUS
Journal:  Arch Pathol       Date:  1964-08

2.  [Morphological findings on the mode of action of oral antidiabetics].

Authors:  J KRACHT; C VON HOLT; L VON HOLT
Journal:  Endokrinologie       Date:  1957

3.  [Histological study of the effect of the hypoglycemic sulphamides on the islands of Langerhans of the rat; study of the effect of BZ-55 treatment associated with cortisone].

Authors:  W GEPTS
Journal:  Ann Endocrinol (Paris)       Date:  1957       Impact factor: 2.478

4.  Cytochalasin B: inhibition of glucose-induced insulin release from isolated rat pancreatic islets.

Authors:  P Schauder; H Frerichs
Journal:  Diabetologia       Date:  1974-02       Impact factor: 10.122

5.  [Isolation of Langerhans' islets from rat pancreas].

Authors:  R Gerner; J L'Age-Stehr; T O Tjioe; A Wacker
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1970-03

6.  [The effect of oral antidiabetics on the biosynthesis of proinsulin in the rat].

Authors:  T O Tjioe; A Wacker
Journal:  Arzneimittelforschung       Date:  1972-11

7.  Inhibition of glucose and tolbutamide-induced insulin release by iodoacetate and antimycin A.

Authors:  R H Georg; K E Sussman; J W Leitner; W M Kirsch
Journal:  Endocrinology       Date:  1971-07       Impact factor: 4.736

8.  The stimulatory effect on insulin secretion in long-term tolbutamide treatment. Immunological determinations of urinary- and serum insulin.

Authors:  K Johansen; H Orskov
Journal:  Acta Endocrinol (Copenh)       Date:  1972-12

9.  Adenylate cyclase in islets of Langerhans. Isolation of islets and regulation of adenylate cyclase activity by various hormones and agents.

Authors:  W N Kuo; D S Hodgins; J F Kuo
Journal:  J Biol Chem       Date:  1973-04-25       Impact factor: 5.157

10.  An inhibitory effect of tolbutamide and glibenclamide (glyburide) on the pancreatic islets of normal animals.

Authors:  J C Dunbar; P P Foà
Journal:  Diabetologia       Date:  1974-02       Impact factor: 10.122

View more
  4 in total

1.  Long-term effects of glibenclamide on the insulin production, oxidative metabolism and quantitative ultrastructure of mouse pancreatic islets maintained in tissue culture at different glucose concentrations.

Authors:  L A Håkan Borg; A Andersson
Journal:  Acta Diabetol Lat       Date:  1981

2.  Insulin secretion and (pro)insulin biosynthesis of cultured mice islets after glibenclamide loading in vitro.

Authors:  B Ziegler; B Wilke; M Ziegler; S Schmidt; H Zühlke
Journal:  Experientia       Date:  1980-04-15

3.  Plasma insulin and glucose levels in maturity onset diabetics treated with chlorpropamide.

Authors:  G M Shenfield; A Logan; D Shirling; J Baird
Journal:  Diabetologia       Date:  1977-08       Impact factor: 10.122

4.  Cytochalasin B: evidence for a membrane-directed action in B-cells from rat pancreatic islets.

Authors:  P Schauder; H Frerichs
Journal:  Pflugers Arch       Date:  1976-06-29       Impact factor: 3.657

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.